Circadian chromatin gating of transposon silencing as a longevity checkpoint

Prof. Anya Ogawa (PhD)· Mar 21, 2026

Mechanism: Age-related NAD+ decline weakens the BMAL1:CLOCK complex, leading to open chromatin at transposable element (TE) loci, which activates inflammation. Readout: Readout: NAD+ boosting restores TE silencing, reducing TE RNA levels by over 50% and significantly lowering the 'Inflammation Score'.

Hypothesis

The circadian clock suppresses aging not only by coordinating repair pathways but also by enforcing rhythmic chromatin states that keep transposable elements (TEs) silenced. Age‑related loss of BMAL1:CLOCK binding at >8,000 to <200 sites in skeletal muscle coincides with closing of >7,000 chromatin regions, creating “circadian deserts” where TE‑rich loci become accessible, leading to retrotransposon transcription, cytoplasmic nucleic‑acid sensing, chronic NFκB activation, and inflammaging. Restoring rhythmic accessibility at these deserts—without necessarily boosting core oscillator amplitude—should re‑establish TE silencing and attenuate age‑related inflammation.

Mechanistic rationale

BMAL1:CLOCK directly recruits histone deacetylases (e.g., SIRT1) and chromatin remodelers to TE promoters, producing repressive H3K9me3 marks during the active phase. When BMAL1:CLOCK occupancy declines, these loci lose rhythmic deacetylation, gain H3K27ac, and become transcriptionally permissive.
TE-derived double‑stranded RNA activates cytosolic sensors (MAVS, cGAS‑STING), amplifying NFκB‑driven ROS and p53/p21 senescence signaling, a loop already linked to clock dysfunction.
The NAD+/SIRT1/NAMPT axis sustains BMAL1:CLOCK chromatin activity; NAD+ decline with age further weakens this repressive gate, creating a feed‑forward destabilization.

Testable predictions

Chromatin accessibility at TE loci will show anti‑phasic rhythmicity in young tissue and become arrhythmic in old tissue.
- Perform ATAC‑seq on sorted muscle fibers from 3‑month vs. 24‑month mice across circadian time; expect loss of rhythmic peaks at LINE‑1, IAP, and ERV promoters in aged samples.
Pharmacological NAD+ boosting (e.g., NR) will restore rhythmic accessibility at TE regions and reduce TE transcripts without markedly increasing BMAL1:CLOCK protein levels.
- Treat aged mice with NR for 4 weeks; assay ATAC‑seq and RNA‑seq for TE expression; predict restored rhythmicity and >50% drop in TE‑derived RNAs.
Targeted dCas9‑KRAB repression of a representative TE promoter in aged muscle will ameliorate NFκB activation and improve muscle function, mimicking clock reinforcement.
- Deliver AAV‑dCas9‑KRAB to muscle of 20‑month mice; measure p65 nuclear translocation, grip strength, and fibrosis; anticipate reduced inflammation and enhanced performance comparable to young controls.
Disrupting the circadian TE gate in young mice (via inducible Bmal1 deletion limited to TE‑rich chromatin) will precipitate premature TE expression and inflammaging despite an intact central SCN clock.
- Use a dual‑system: tamoxifen‑inducible Bmal1 floxed plus a TE‑specific Cre driver; assess TE RNA, serum IL‑6, and frailty index; expect accelerated aging phenotypes.

Falsifiability

If rhythmic chromatin accessibility at TE loci does not decline with age, or if restoring NAD+ fails to re‑establish TE silencing and inflammaging markers, the hypothesis would be refuted. Conversely, confirmation would position the circadian clock as a genome‑wide transposon firewall, suggesting that geroprotective strategies should prioritize chromatin gatekeeping over mere oscillator amplification.

Hypothesis

Mechanistic rationale

BMAL1:CLOCK directly recruits histone deacetylases (e.g., SIRT1) and chromatin remodelers to TE promoters, producing repressive H3K9me3 marks during the active phase. When BMAL1:CLOCK occupancy declines, these loci lose rhythmic deacetylation, gain H3K27ac, and become transcriptionally permissive.

TE-derived double‑stranded RNA activates cytosolic sensors (MAVS, cGAS‑STING), amplifying NFκB‑driven ROS and p53/p21 senescence signaling, a loop already linked to clock dysfunction.

The NAD+/SIRT1/NAMPT axis sustains BMAL1:CLOCK chromatin activity; NAD+ decline with age further weakens this repressive gate, creating a feed‑forward destabilization.

Testable predictions

Chromatin accessibility at TE loci will show anti‑phasic rhythmicity in young tissue and become arrhythmic in old tissue.

Perform ATAC‑seq on sorted muscle fibers from 3‑month vs. 24‑month mice across circadian time; expect loss of rhythmic peaks at LINE‑1, IAP, and ERV promoters in aged samples.

Pharmacological NAD+ boosting (e.g., NR) will restore rhythmic accessibility at TE regions and reduce TE transcripts without markedly increasing BMAL1:CLOCK protein levels.

Treat aged mice with NR for 4 weeks; assay ATAC‑seq and RNA‑seq for TE expression; predict restored rhythmicity and >50% drop in TE‑derived RNAs.

Targeted dCas9‑KRAB repression of a representative TE promoter in aged muscle will ameliorate NFκB activation and improve muscle function, mimicking clock reinforcement.

Deliver AAV‑dCas9‑KRAB to muscle of 20‑month mice; measure p65 nuclear translocation, grip strength, and fibrosis; anticipate reduced inflammation and enhanced performance comparable to young controls.

Disrupting the circadian TE gate in young mice (via inducible Bmal1 deletion limited to TE‑rich chromatin) will precipitate premature TE expression and inflammaging despite an intact central SCN clock.

Use a dual‑system: tamoxifen‑inducible Bmal1 floxed plus a TE‑specific Cre driver; assess TE RNA, serum IL‑6, and frailty index; expect accelerated aging phenotypes.

Falsifiability